SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Biopharma Update on the Novel Coronavirus: September 4
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
September 3, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Courtesy of Willy Barton/Getty Images
Business
Sanofi, GSK Move COVID-19 Vaccine Candidate Into the Clinic, Expect Data by December
Months after forging a development partnership for a COVID-19 vaccine, GlaxoSmithKline and Sanofi are moving their adjuvanted vaccine candidate into the clinic.
September 3, 2020
 · 
2 min read
 · 
Alex Keown
Business
BioSpace Global Roundup, Sept. 3
Biopharma and life science companies from across the globe provide updates on their pipelines and businesses.
September 2, 2020
 · 
7 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: September 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 2, 2020.
September 1, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 31, 2020.
August 31, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: August 24-28
As August wraps up, there were still clinical trial announcements, although fewer than earlier this summer. Here’s a look.
August 31, 2020
 · 
5 min read
 · 
Mark Terry
Business
Biopharma Update on the Novel Coronavirus: August 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 28, 2020.
August 28, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Phase I Data Suggests Moderna’s COVID-19 Vaccine is Effective Across Age Groups
Moderna presented more detailed data from the Phase I trial of its mRNA COVID-19 vaccine at the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today.
August 26, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020.
August 25, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: August 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 24, 2020.
August 24, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Drug Development
Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea
July 8, 2024
 · 
2 min read
Drug Development
Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication
July 3, 2024
 · 
4 min read
Drug Development
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
July 3, 2024
 · 
7 min read
Drug Development
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
July 3, 2024
 · 
7 min read
Press Releases
Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024
July 2, 2024
 · 
8 min read
Drug Development
Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Topical ET-02 for the Treatment of Androgenic Alopecia
July 1, 2024
 · 
3 min read
Drug Development
Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
July 1, 2024
 · 
5 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
July 1, 2024
 · 
7 min read
Press Releases
SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors
June 30, 2024
 · 
3 min read
Drug Development
KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase 1 Study
June 28, 2024
 · 
5 min read
Drug Development
BridGene Biosciences Announces Dosing of First Patient in Phase 1 Study Evaluating Novel TEAD Inhibitor BGC515 in Advanced Solid Tumors
June 28, 2024
 · 
3 min read
Drug Development
Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
June 27, 2024
 · 
4 min read
Drug Development
Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
June 27, 2024
 · 
6 min read
Drug Development
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
June 27, 2024
 · 
5 min read
Drug Development
Quanta Announces Dosing of First Patient in Phase 1/1b Clinical Trial of QTX3046, an Oral KRASᴳ¹²ᴰ-Selective Dual-State Allosteric Inhibitor, and Other Program Updates
June 27, 2024
 · 
5 min read
Drug Development
Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a Non-covalent Reversible BTK Inhibitor with Once Daily Dosing Potential
June 27, 2024
 · 
4 min read
Drug Development
Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients
June 27, 2024
 · 
9 min read
Drug Development
FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
June 27, 2024
 · 
10 min read
Drug Development
Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer
June 27, 2024
 · 
8 min read
Drug Development
STALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in Biomedicines
June 27, 2024
 · 
3 min read
Load More